Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...
AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...
Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...
Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
On November 2, 2025, the research group led by Dr. Zeng Ling from Army Medical University systematically elucidated the molecular mechanisms, ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
The collaboration provides Agenus with strategic capital and committed, long-term biologics manufacturing capacity in the United States to support BOT+BAL clinical development, authorized early access ...
Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.
Health-wise, lemongrass has been associated with mild antimicrobial, anti-inflammatory and calming effects. When used in everyday cooking or as a tea, lemongrass may help with digestion, support ...
Live Science on MSN
'Zombie' cells may drive common form of epilepsy
Scientists are unraveling the role of senescent cells in a common form of epilepsy, and it could point to new treatments.
Morning Overview on MSN
Why octopuses literally rip themselves apart after mating
Among animals, few life cycles are as dramatic as that of the octopus. After a single reproductive event, many females enter ...
4don MSN
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results